Search research articles
Contact Us
Filters
Showing results (191-200 of 22,548) with videos related to
Page
of 2,255
Sort By:
Oncogene
|
October 12, 2010
Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis
J Li, Y Cheng, D Tai, et al.
Oncogene
|
October 12, 2010
Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis
K L Decicco-Skinner, E L Trovato, J K Simmons, et al.
Oncogene
|
October 12, 2010
Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression
J Ahn, M Ko, C Lee, et al.
Oncogene
|
March 1, 1990
Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle
S M Anderson, P M Carroll, F D Lee
Oncogene
|
March 1, 1990
Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene
W L Hsiao, H L Pai, M S Matsui, et al.
Oncogene
|
November 3, 2010
P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer
J C Montero, S Seoane, A Ocaña, et al.
Oncogene
|
November 3, 2010
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer
B A Patrick, X Gong, A K Jaiswal
Oncogene
|
September 15, 2010
eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer
S-H Goh, S-H Hong, S-H Hong, et al.
Oncogene
|
September 15, 2010
Serine/threonine phosphatases in the DNA damage response and cancer
A Peng, J L Maller
Oncogene
|
September 15, 2010
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
J Kalra, B W Sutherland, A L Stratford, et al.
Page
of 2,255
Search research articles
Search
Showing results (191-200 of 22,548) with videos related to
Sort By:
Page
of 2,255
Oncogene
|
October 12, 2010
Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis
J Li, Y Cheng, D Tai, et al.
Oncogene
|
October 12, 2010
Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis
K L Decicco-Skinner, E L Trovato, J K Simmons, et al.
Oncogene
|
October 12, 2010
Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression
J Ahn, M Ko, C Lee, et al.
Oncogene
|
March 1, 1990
Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle
S M Anderson, P M Carroll, F D Lee
Oncogene
|
March 1, 1990
Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene
W L Hsiao, H L Pai, M S Matsui, et al.
Oncogene
|
November 3, 2010
P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer
J C Montero, S Seoane, A Ocaña, et al.
Oncogene
|
November 3, 2010
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer
B A Patrick, X Gong, A K Jaiswal
Oncogene
|
September 15, 2010
eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer
S-H Goh, S-H Hong, S-H Hong, et al.
Oncogene
|
September 15, 2010
Serine/threonine phosphatases in the DNA damage response and cancer
A Peng, J L Maller
Oncogene
|
September 15, 2010
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
J Kalra, B W Sutherland, A L Stratford, et al.
Page
of 2,255